Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 204370
Company: ALLERGAN SALES LLC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
VRAYLAR CARIPRAZINE HYDROCHLORIDE EQ 1.5MG BASE CAPSULE;ORAL Prescription None Yes No
VRAYLAR CARIPRAZINE HYDROCHLORIDE EQ 3MG BASE CAPSULE;ORAL Prescription None Yes No
VRAYLAR CARIPRAZINE HYDROCHLORIDE EQ 4.5MG BASE CAPSULE;ORAL Prescription None Yes No
VRAYLAR CARIPRAZINE HYDROCHLORIDE EQ 6MG BASE CAPSULE;ORAL Prescription None Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/17/2015 ORIG-2 Approval Efficacy STANDARD

Label is not available on this site.

09/17/2015 ORIG-1 Approval Type 1 - New Molecular Entity STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204370lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204370Orig1Orig2s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/204370Orig2s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/09/2017 SUPPL-3 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204370s002s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/0204370Orig1s002s003ltr.pdf
11/09/2017 SUPPL-2 Efficacy-Labeling Change With Clinical Data Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204370s002s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/0204370Orig1s002s003ltr.pdf
02/23/2017 SUPPL-1 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204370s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204370Orig1s001ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/09/2017 SUPPL-3 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204370s002s003lbl.pdf
11/09/2017 SUPPL-2 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204370s002s003lbl.pdf
02/23/2017 SUPPL-1 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204370s001lbl.pdf
09/17/2015 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204370lbl.pdf

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English